Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Growth Metrics

United Health Products (UEEC) Short-Term Debt repayments (2018 - 2019)

United Health Products' Short-Term Debt repayments history spans 2 years, with the latest figure at -$61135.0 for Q4 2019.

Quarterly results put Short-Term Debt repayments at -$61135.0 for Q4 2019, up 59.7% from a year ago — trailing twelve months through Dec 2019 was -$286342.0 (up 3.0% YoY), and the annual figure for FY2022 was $14525.0, up 139.79%.
Short-Term Debt repayments for Q4 2019 was -$61135.0 at United Health Products, up from -$151707.0 in the prior quarter.
In the past five years, Short-Term Debt repayments ranged from a high of -$8500.0 in Q2 2018 to a low of -$151707.0 in Q4 2018.